Last Updated: September 29, 2026

Details for New Drug Application (NDA): 207795

✉ Email this page to a colleague

NDA 207795 describes VYZULTA, which is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the VYZULTA profile page.

The generic ingredient in VYZULTA is latanoprostene bunod. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the latanoprostene bunod profile page.

Summary for 207795

Tradename:	VYZULTA
Applicant:	Bausch And Lomb
Ingredient:	latanoprostene bunod
Patents:	1

Suppliers and Packaging for NDA: 207795

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
VYZULTA	latanoprostene bunod	SOLUTION/DROPS;OPHTHALMIC	207795	NDA	Bausch & Lomb Incorporated	24208-504	24208-504-01	1 BOTTLE in 1 CARTON (24208-504-01) / 2.5 mL in 1 BOTTLE
VYZULTA	latanoprostene bunod	SOLUTION/DROPS;OPHTHALMIC	207795	NDA	Bausch & Lomb Incorporated	24208-504	24208-504-02	1 BOTTLE in 1 CARTON (24208-504-02) / 2.5 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.024%
Approval Date:	Nov 2, 2017	TE:	AB	RLD:	Yes
Patent:	⤷ Start Trial	Patent Expiration:	Feb 21, 2029	Product Flag?		Substance Flag?	Y	Delist Request?
Patented Use:	REDUCTION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION

Expired US Patents for NDA 207795

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch And Lomb	VYZULTA	latanoprostene bunod	SOLUTION/DROPS;OPHTHALMIC	207795-001	Nov 2, 2017	⤷ Start Trial	⤷ Start Trial
Bausch And Lomb	VYZULTA	latanoprostene bunod	SOLUTION/DROPS;OPHTHALMIC	207795-001	Nov 2, 2017	⤷ Start Trial	⤷ Start Trial
Bausch And Lomb	VYZULTA	latanoprostene bunod	SOLUTION/DROPS;OPHTHALMIC	207795-001	Nov 2, 2017	⤷ Start Trial	⤷ Start Trial
Bausch And Lomb	VYZULTA	latanoprostene bunod	SOLUTION/DROPS;OPHTHALMIC	207795-001	Nov 2, 2017	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.